✦ LIBER ✦

O141 Micafungin versus liposomal amphotericin B (AmBisome ®) in paediatric patients with invasive candidiasis or candidaemia

✍ Scribed by A. Arrieta; F. Queiroz-Telles; E. Berezin; A. Freire; S. Diekmann; S. Koblinger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Economic analysis of micafungin versus l

✍ Cornely, O. A.; Sidhu, M.; Odeyemi, I.; van Engen, A. K.; van der Waal, J. M.; S 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 230 KB

PIN13 ECONOMIC ANALYSIS OF MICAFUNGIN VE

✍ P Viale; M Sidhu; A van Engen; O Schoeman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PIN27 ECONOMIC ANALYSIS OF MICAFUNGIN VE

✍ G Park; M Sidhu; AK Van Engen; O Schoeman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

P972 A review of the safety of micafungi

✍ A.J. Ullmann; J. De Waele; R. Betts; C. Rotstein; M. Nucci; O.A. Cornely 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

O140 Micafungin versus caspofungin in pa

✍ B. Dupont; J. De Waele; R. Betts; C. Rotstein; M. Nucci; L. Arnold; L. Kovanda; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 50 KB

PIN16 COST-EFFECTIVENESS ANALYSIS OF MIC

✍ A Odeyemi; WM Hart; II Odeyemi; P Musingarimi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB